Qingdao Haier Biomedical Co Ltd (688139) — Cash Flow Reinvestment Rate
Qingdao Haier Biomedical Co Ltd (688139) has a Cash Flow Reinvestment Rate of 10.07x as of June 2023, reinvesting CN¥73.78 Million (capex CN¥53.93 Million plus investments CN¥19.85 Million) from operating cash flow of CN¥7.33 Million. See Qingdao Haier Biomedical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Qingdao Haier Biomedical Co Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Qingdao Haier Biomedical Co Ltd across 10 annual periods. For the full cash flow conversion analysis, see 688139 cash flow metrics.
Annual Cash Flow Reinvestment Rate for Qingdao Haier Biomedical Co Ltd (2016–2025)
Year-by-year capital reinvestment analysis for Qingdao Haier Biomedical Co Ltd. See Qingdao Haier Biomedical Co Ltd (688139) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.16x | CN¥311.45 Million | CN¥267.89 Million | CN¥119.25 Million | ▼ -46.3% |
| 2024 | 2.17x | CN¥631.63 Million | CN¥291.67 Million | CN¥126.70 Million | ▲ +25.6% |
| 2023 | 1.72x | CN¥429.94 Million | CN¥249.26 Million | CN¥177.18 Million | ▲ +202.8% |
| 2022 | 0.57x | CN¥360.26 Million | CN¥632.43 Million | CN¥294.24 Million | ▼ -82.3% |
| 2021 | 3.21x | CN¥2.03 Billion | CN¥632.43 Million | CN¥204.69 Million | ▲ +446.5% |
| 2020 | 0.59x | CN¥409.39 Million | CN¥696.62 Million | CN¥88.99 Million | ▼ -75.3% |
| 2019 | 2.38x | CN¥668.07 Million | CN¥280.49 Million | CN¥168.40 Million | ▼ -54.5% |
| 2018 | 5.24x | CN¥780.26 Million | CN¥149.00 Million | CN¥69.33 Million | ▲ +468.1% |
| 2017 | 0.92x | CN¥136.72 Million | CN¥148.32 Million | CN¥26.98 Million | ▼ -53.5% |
| 2016 | 1.98x | CN¥437.81 Million | CN¥220.72 Million | CN¥14.50 Million | — |